Literature DB >> 2738663

A radiosynthesis of fluorine-18 fluoromisonidazole.

J R Grierson1, J M Link, C A Mathis, J S Rasey, K A Krohn.   

Abstract

A new preparation of [18F]fluoromisonidazole [1H-1-(3-[18F] fluoro-2-hydroxypropyl)-2-nitroimidazole] is presented as a two-step, two-pot reaction sequence. The method is useful for the production of 20-30 mCi quantities of this compound from [18F]fluoride, available in 40% radiochemical yield at end of bombardment (EOB) with a specific activity (nca) of greater than 650 Ci/mmol (EOB) and a synthesis time of approximately 140 min. The key feature of the reaction scheme is the preparation of a new fluoroalkylating agent, [18F]epifluorohydrin.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2738663

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  25 in total

Review 1.  Tracers for metabolic imaging of brain and heart. Radiochemistry and radiopharmacology.

Authors:  G Stöcklin
Journal:  Eur J Nucl Med       Date:  1992

Review 2.  Biological validation of electron paramagnetic resonance (EPR) image oxygen thresholds in tissue.

Authors:  Inna Gertsenshteyn; Mihai Giurcanu; Peter Vaupel; Howard Halpern
Journal:  J Physiol       Date:  2020-06-28       Impact factor: 5.182

3.  Fluorine-18 fluoromisonidazole tumour to muscle retention ratio for the detection of hypoxia in nasopharyngeal carcinoma.

Authors:  S H Yeh; R S Liu; L C Wu; D J Yang; S H Yen; C W Chang; T W Yu; K L Chou; K Y Chen
Journal:  Eur J Nucl Med       Date:  1996-10

4.  Image-guided PO2 probe measurements correlated with parametric images derived from 18F-fluoromisonidazole small-animal PET data in rats.

Authors:  Rachel M Bartlett; Bradley J Beattie; Manoj Naryanan; Jens-Christoph Georgi; Qing Chen; Sean D Carlin; Gordon Roble; Pat B Zanzonico; Mithat Gonen; Joseph O'Donoghue; Alexander Fischer; John L Humm
Journal:  J Nucl Med       Date:  2012-08-29       Impact factor: 10.057

Review 5.  PET radiopharmaceuticals for imaging of tumor hypoxia: a review of the evidence.

Authors:  Egesta Lopci; Ilaria Grassi; Arturo Chiti; Cristina Nanni; Gianfranco Cicoria; Luca Toschi; Cristina Fonti; Filippo Lodi; Sandro Mattioli; Stefano Fanti
Journal:  Am J Nucl Med Mol Imaging       Date:  2014-06-07

Review 6.  Imaging tumor hypoxia to advance radiation oncology.

Authors:  Chen-Ting Lee; Mary-Keara Boss; Mark W Dewhirst
Journal:  Antioxid Redox Signal       Date:  2014-03-24       Impact factor: 8.401

Review 7.  Fluorinated tracers for imaging cancer with positron emission tomography.

Authors:  Olivier Couturier; André Luxen; Jean-François Chatal; Jean-Philippe Vuillez; Pierre Rigo; Roland Hustinx
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-07-06       Impact factor: 9.236

Review 8.  Tumor hypoxia: a new PET imaging biomarker in clinical oncology.

Authors:  Nagara Tamaki; Kenji Hirata
Journal:  Int J Clin Oncol       Date:  2015-11-14       Impact factor: 3.402

9.  Synthesis and characterization of a hypoxia-sensitive MRI probe.

Authors:  Federico A Rojas-Quijano; Gyula Tircsó; Enikő Tircsóné Benyó; Zsolt Baranyai; Huan Tran Hoang; Ferenc K Kálmán; Praveen K Gulaka; Vikram D Kodibagkar; Silvio Aime; Zoltán Kovács; A Dean Sherry
Journal:  Chemistry       Date:  2012-06-27       Impact factor: 5.236

10.  In vivo assessment of tumor hypoxia in lung cancer with 60Cu-ATSM.

Authors:  Farrokh Dehdashti; Mark A Mintun; Jason S Lewis; Jeffrey Bradley; Ramaswamy Govindan; Richard Laforest; Michael J Welch; Barry A Siegel
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-04-12       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.